Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-083072
Filing Date
2015-12-03
Accepted
2015-12-03 10:05:14
Documents
1
Period of Report
2015-12-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3308
  Complete submission text file 0001209191-15-083072.txt   5272
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Issuer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: CO | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Reporting) CIK: 0001411906 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-53121 | Film No.: 151266425
SIC: 2834 Pharmaceutical Preparations